$BFRI Cashflow Statement | Understand Stock

$BFRI

$0.84 +$0.02 (2.17%) Close

$BFRI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss

Gain on legal settlement
Depreciation
Depreciation and amortization
Reduction in the carrying amount of right-of-use assets
Amortization of acquired intangible assets
Stock-based compensation
Provision for inventory obsolescence
Non-cash interest expense
Allowance for credit losses
Change in fair value of warrant liabilities
Warrant inducement expense
Excess of warrant fair value over offering proceeds
Gain on sale of asset held for sale
Loss from termination of operating leases
Realized/unrealized loss in investment, related party
Change in fair value of contingent consideration
Loss on debt extinguishment
Changes in operating assets and liabilities:
Accounts receivable
Other receivables, related party
Prepaid expenses and other assets
Other assets, related party
Inventories
Accounts payable and related party payables
Accounts payable
Accounts payable, related parties, net
Operating lease liabilities
Accrued expenses and other liabilities
Cash flows used in operating activities
Purchases of investment, related party
Purchases of property and equipment
Proceeds from sale of asset held for sale
Sales of investment, related party
Purchase of intangible assets
Purchases of property and equipment
Cash flows provided by (used in) investing activities
Cash flows from financing activities
Proceeds from issuance of Series C preferred stock, net of offering costs
Proceeds from issuance of Series B-1 preferred stock and warrants to purchase series B-3 preferred stock, net of issuance costs
Proceeds from issuance of Series B-3 preferred stock from exercise of warrants
Proceeds from issuance of convertible notes, net of issuance costs
Proceeds from line of credit
Proceeds from issuance of common stock and warrants
Proceeds from issuance of private placement
Proceeds from exercise of warrants
Proceeds from short term debt
Payment of principal short-term debt
Cash flows provided by financing activities

Net increase in cash and cash equivalents
Cash, cash equivalents and restricted cash, at the beginning of the year
Cash, cash equivalents and restricted cash, at the end of the year
Supplemental non-cash investing and financing activities
Interest paid
Interest paid, related party
Income tax paid, net

Release of start-up cost financing obligation as part of legal settlement
Release of contingent consideration obligation as part of legal settlement
Transfer of investment as part of legal settlement
Addition of right-of-use assets in exchange for operating lease liabilities
Issuance costs included in accrued expenses and other liabilities
Conversion of warrant liability to equity in connection with exercise of warrants
Issuance of common shares in exchange for investment, related party
Preferred stock issued as consideration in asset purchase acquisition (See Note 3. Asset Acquisition)
Property, plant and equipment acquired
Conversion of warrant liability to equity
Intangible asset acquired
Addition of right-of-use assets in exchange for operating lease liabilities

Comments